Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00781534 · ClinicalTrials.gov registry record · Early Phase 1
A Clinical Trial of Ginseng in Diabetes
A Early Phase 1 study, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 19
- Enrollment target
NCT00781534: Completed Early Phase 1 study, sponsored by Washington University School of Medicine.
NCT00781534 is a Early Phase 1 study that has completed, run by Washington University School of Medicine. The registered enrollment target is 19 participants, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (64% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00781534, a Early Phase 1 study, has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 19 participants
- Enrollment target
Study Summary
a clinical study of Ginseng its potential affect on diabetes
Interventions
- DRUG Ginseng
- DRUG ginsenoside RE
- DIETARY_SUPPLEMENT Placebo (sugar pill)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2003-09 |
| Est. Completion | 2008-09 |
| Phase | Early Phase 1 |
What the finished NCT00781534 record still lists
NCT00781534 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 19 participants, a relatively small participant target, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (64% lower).
The record links to 0 conditions, and to 3 interventions - of which Ginseng is the first listed.
NCT00781534 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00781534 about?
NCT00781534 is a clinical study titled "A Clinical Trial of Ginseng in Diabetes". a clinical study of Ginseng its potential affect on diabetes
What is the current status of trial NCT00781534?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 19 participants. The study started on 2003-09. Estimated completion is 2008-09.
What interventions are being tested in trial NCT00781534?
The interventions under investigation include: Ginseng (DRUG), ginsenoside RE (DRUG), Placebo (sugar pill) (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00781534?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00781534's enrollment target sits among peer trials
19 1292nd of 2000 higher than 686 of 2,000 other Early Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Early Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03207464 · 19 participants · Phase 1
Molecular Imaging of NET Using [C-11]MRB-PET in MS
- NCT04318717 · 19 participants · Phase 2
Pembrolizumab and Hypofractionated Radiation Therapy for the Treatment of Mucosal Melanoma
- NCT05103904 · 19 participants · Phase 2
Lenvatinib for the Treatment of Recurrent Hepatocellular Carcinoma After Liver Transplant
- NCT05607407 · 19 participants · Phase 2
Methimazole in Patients With Progressive Glioblastoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia